Search
Now showing items 1-10 of 34
BRAF mutations in chronic lymphocytic leukemia
Jebaraj, Billy Michael Chelliah et al. (2013)
Wissenschaftlicher Artikel
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia
Hopfinger, Georg et al. (2013)
Wissenschaftlicher Artikel
Telomere length in mantle cell lymphoma
Jebaraj, Billy Michael Chelliah et al. (2013)
Wissenschaftlicher Artikel
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG
Schnaiter, Andrea et al. (2013)
Wissenschaftlicher Artikel
Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment
Schulz, Angela et al. (2013)
Wissenschaftlicher Artikel
Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia
Goebel, Maria et al. (2013)
Wissenschaftlicher Artikel
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial
Dreger, Peter et al. (2013)
Wissenschaftlicher Artikel
Epigenetic Upregulation of IncRNAs at 13q14.3 in Leukemia Is Linked to the In Cis Downregulation of a Gene Cluster That Targets NF-kB
Garding, Angela et al. (2013)
Wissenschaftlicher Artikel
Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study Group
Cramer, Paula et al. (2013)
Wissenschaftlicher Artikel
GSM543450: 56 CD14CLL4_4403827073_H
Bhattacharya, Nupur; Mertens, Daniel; Stilgenbauer, Stephan; Doehner, Hartmut (2013)
Forschungsdaten